全部成果分类

导出
  • 排序
  • 显示
3. Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study SCIE PubMed SCOPUS

作者:Leng, Y; Hou, J; Jin, J; Zhang, M; Ke, XY; Jiang, B; Pan, L; Yang, LH; Zhou, F; Wang, JM; Wang, Z; Liu, L; Li, W; Shen, ZX; Qiu, LG; Chang, NN; Li, JY; Liu, J; Pang, HY; Meng, HT; Wei, P; Jiang, H; Liu, Y; Zheng, XJ; Yang, SF; Chen, WM

作者机构:[Leng, Yun; Chen, Wenming] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing, Peoples R China.; [Hou, Jian; Jiang, Hua] Second Mil Med 更多

关键词:Dexamethasone; Multiple myeloma; Phase 2 clinical trials; Recombinant human circularly permuted TRAIL; Thalidomide

来源:CANCER CHEMOTHERAPY AND PHARMACOLOGY,2017,Vol.79,Issue.6

Scopus被引频次:6

ESI学科:CLINICAL MEDICINE

最新一期影响因子:2.737

资源类型:外文期刊论文

TOP